Suppr超能文献

肌钙蛋白T2(TNNT2)中与肥厚型心肌病(HCM)相关的Arg92Leu突变通过变构作用改变肌钙蛋白C(cTnC)-肌钙蛋白I(cTnI)界面,并破坏蛋白激酶A(PKA)介导的肌丝舒张调节。

The HCM - Linked Mutation Arg92Leu in TNNT2 Allosterically Alters the cTnC - cTnI Interface and Disrupts the PKA-mediated Regulation of Myofilament Relaxation.

作者信息

Lynn Melissa L, Jimenez Jesus, Castillo Romi L, Klass Matthew M, Vasquez Catherine, Baldo Anthony, Gibson Cyonna, Murphy Anne M, Tardiff Jil C

出版信息

bioRxiv. 2023 Jul 19:2023.07.18.549569. doi: 10.1101/2023.07.18.549569.

Abstract

BACKGROUND

Impaired left ventricular relaxation, high filling pressures, and dysregulation of Ca homeostasis are common findings contributing to diastolic dysfunction in hypertrophic cardiomyopathy (HCM). Studies have shown that impaired relaxation is an early observation in the sarcomere-gene-positive preclinical HCM cohort which suggests potential involvement of myofilament regulators of relaxation. Yet, a molecular level understanding of mechanism(s) at the level of the myofilament is lacking. We hypothesized that mutation-specific, allosterically mediated, changes to the cardiac troponin C-cardiac troponin I (cTnC-cTnI) interface can account for the development of early-onset diastolic dysfunction via decreased PKA accessibility to cTnI.

METHODS

HCM mutations R92L-cTnT (Arg92Leu) and Δ160E-cTnT (Glu160 deletion) were studied , and via 2D echocardiography, western blotting, hemodynamics, stopped-flow kinetics, time resolved fluorescence resonance energy transfer (TR-FRET), and molecular dynamics simulations.

RESULTS

The HCM-causative mutations R92L-cTnT and Δ160E-cTnT result in different time-of-onset of diastolic dysfunction. R92L-cTnT demonstrated early-onset diastolic dysfunction accompanied by a localized decrease in phosphorylation of cTnI. Constitutive phosphorylation of cTnI (cTnI-D D ) was sufficient to recover diastolic function to Non-Tg levels only for R92L-cTnT. Mutation-specific changes in Ca dissociation rates associated with R92L-cTnT reconstituted with cTnI-D D led us to investigate potential involvement of structural changes in the cTnC-cTnI interface as an explanation for these observations. We probed the interface via TR-FRET revealing a repositioning of the N-terminus of cTnI, closer to cTnC, and concomitant decreases in distance distributions at sites flanking the PKA consensus sequence. Implementing TR-FRET distances as constraints into our atomistic model identified additional electrostatic interactions at the consensus sequence.

CONCLUSION

These data indicate that the early diastolic dysfunction observed in a subset of HCM is likely attributable to structural changes at the cTnC-cTnI interface that impair accessibility of PKA thereby blunting β-adrenergic responsiveness and identifying a potential molecular target for therapeutic intervention.

摘要

背景

左心室舒张功能受损、高充盈压以及钙稳态失调是肥厚型心肌病(HCM)舒张功能障碍的常见表现。研究表明,舒张功能受损是肌节基因阳性临床前HCM队列中的早期观察结果,这表明舒张的肌丝调节因子可能参与其中。然而,目前缺乏对肌丝水平机制的分子层面理解。我们假设,心脏肌钙蛋白C-心脏肌钙蛋白I(cTnC-cTnI)界面的突变特异性、变构介导的变化可通过降低蛋白激酶A(PKA)与cTnI的结合能力来解释早发性舒张功能障碍的发生。

方法

对HCM突变R92L-cTnT(精氨酸92位突变为亮氨酸)和Δ160E-cTnT(谷氨酸160缺失)进行了研究,采用二维超声心动图、蛋白质印迹法、血流动力学、停流动力学、时间分辨荧光共振能量转移(TR-FRET)以及分子动力学模拟。

结果

导致HCM的突变R92L-cTnT和Δ160E-cTnT导致舒张功能障碍的发病时间不同。R92L-cTnT表现为早发性舒张功能障碍,伴有cTnI磷酸化的局部降低。仅对于R92L-cTnT,cTnI的组成型磷酸化(cTnI-DD)足以使舒张功能恢复到非转基因水平。与cTnI-DD重构的R92L-cTnT相关的钙解离速率的突变特异性变化,促使我们研究cTnC-cTnI界面结构变化的潜在参与情况,以解释这些观察结果。我们通过TR-FRET探测该界面,发现cTnI的N端重新定位,更靠近cTnC,并且PKA共有序列侧翼位点的距离分布随之减小。将TR-FRET距离作为约束条件应用于我们的原子模型,确定了共有序列处的额外静电相互作用。

结论

这些数据表明,在一部分HCM中观察到的早期舒张功能障碍可能归因于cTnC-cTnI界面的结构变化,这种变化损害了PKA的结合能力,从而减弱了β-肾上腺素能反应性,并确定了一个潜在的治疗干预分子靶点。

相似文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验